Showing results (71-80 of 120) with videos related to
Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2024
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With CancerFrancisco Bautista, Jaime Verdú-Amorós, Birgit Geoerger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.Radiology|November 22, 2012
Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaYann Jamin, Elizabeth R Tucker, Evon Poon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force reportTom Monclair, Garrett M Brodeur, Peter F Ambros, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2010
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group ProjectVeronica Moroz, David Machin, Andreas Faldum, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed NeuroblastomaJane Carr-Wilkinson, Kieran O'Toole, Katrina M Wood, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplificationBruno De Bernardi, Mary Gerrard, Luca Boni, et al.Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.Plos One|April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentDorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.Pageof 12